BioCryst Pharmaceuticals | Sasa Madeni

Name: BioCryst Pharmaceuticals | Sasa Madeni
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Current Liabilities		Tarehe
Adamas Pharmaceuticals ADMS:US	$ 34.87M	3.38M	2020-12
Alexion Pharmaceuticals ALXN:US	$ 1624.7M	293.7M	2020-12
Alnylam Pharmaceuticals ALNY:US	$ 585.27M	105.03M	2020-12
Biocryst Pharmaceuticals BCRX:US	$ 105.65M	6.12M	2020-12
Chugai Pharma 4519:JP	Y 236070M	51392M	2020-12
Daiichi Sankyo 4568:JP	Y 313298M	16660M	2020-12
Enanta Pharmaceuticals ENTA:US	$ 23.04M	1.11M	2020-12
Gilead Sciences GILD:US	$ 11397M	1888M	2020-12
GlaxoSmithKline GSK:LN	22148M	31M	2020-12
Glaxosmithkline GSK:US	$ 22148M	31M	2020-12
Intra Cellular Therapies ITCI:US	$ 36.85M	1.18M	2020-12
IONIS PHARMACEUT IONS:US	$ 583.25M	338.68M	2020-12
Karyopharm Therapeutics KPTI:US	$ 60.2M	7.57M	2020-12
Mirati Therapeutics MRTX:US	$ 71.47M	4.11M	2020-12
Neurocrine Biosciences NBIX:US	$ 186.5M	424.5M	2020-12
Ptc Therapeutics PTCT:US	$ 277.33M	23.51M	2020-12
Regeneron Pharmaceuticals REGN:US	$ 2697.4M	359.6M	2020-12
Ultragenyx Pharmaceutical RARE:US	$ 189.61M	11.58M	2020-12
Vertex Pharmaceuticals VRTX:US	$ 1877.53M	126.49M	2020-12
YTE INCY:US	$ 631.2M	24.99M	2020-12
Zogenix ZGNX:US	$ 82.72M	9.59M	2020-12

BioCryst Pharmaceuticals Sasa Madeni - Sasa, maadili, data ya kihistoria, utabiri, takwimu, chati na kalenda ya kiuchumi - Mar 2021.